Jaguar Health, Inc.
JAGX
$0.31
-$0.05-14.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.79M | 29.54M | 11.51M | 11.79M | 11.81M |
| Total Other Revenue | 25.00K | 25.00K | -- | -- | -- |
| Total Revenue | 27.82M | 29.57M | 11.51M | 11.79M | 11.81M |
| Cost of Revenue | 4.92M | 4.42M | 3.77M | 2.13M | 2.14M |
| Gross Profit | 22.89M | 25.15M | 7.74M | 9.65M | 9.67M |
| SG&A Expenses | 22.75M | 25.49M | 27.88M | 27.29M | 26.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.91M | 55.07M | 56.62M | 44.61M | 44.66M |
| Operating Income | -25.10M | -25.51M | -45.11M | -32.82M | -32.85M |
| Income Before Tax | -36.92M | -34.68M | -54.00M | -41.04M | -41.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.92 | -34.68 | -54.00 | -41.04 | -41.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 524.00K | 557.00K | 563.00K | 745.00K | 766.00K |
| Net Income | -36.40M | -34.12M | -53.43M | -40.29M | -40.65M |
| EBIT | -25.10M | -25.51M | -45.11M | -32.82M | -32.85M |
| EBITDA | -23.19M | -23.60M | -43.20M | -30.91M | -30.94M |
| EPS Basic | -402.32 | -745.56 | -1.32K | -1.73K | -2.43K |
| Normalized Basic EPS | -223.21 | -399.26 | -773.35 | -1.03K | -1.46K |
| EPS Diluted | -402.32 | -745.56 | -1.32K | -1.73K | -2.43K |
| Normalized Diluted EPS | -223.21 | -399.26 | -773.35 | -1.03K | -1.46K |
| Average Basic Shares Outstanding | 1.52M | 739.40K | 241.50K | 107.50K | 75.00K |
| Average Diluted Shares Outstanding | 1.52M | 739.40K | 241.50K | 107.50K | 75.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |